TGFB1 and cancer: Interestingly, the ‘lymphocyte‐depleted’ and ‘TGF‐β‐dominant’ immune subtypes were both reported by Thorsson et al. (2018) to have the least favorable outcome among all the pan‐cancer subtypes, a finding in accordance with the overall poor prognosis of GBMs.